Education and Training
Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer
Human Basal Cell Carcinomas (BCCs) can be ablated by treating them with nanosecond pulsed electric fields (nsPEF)
Stanford is currently not accepting patients for this trial.
Intervention(s):
- device: PulseCure pulse generator and Derm-pulse electrode
Eligibility
Inclusion Criteria:
1. Study subjects must have had diagnosed at least one BCCon their trunk
2. The subject is from 18-75 years of age, inclusive.
3. The subject must sign and date all informed consent statements.
Exclusion Criteria:
1. The subject is exhibiting signs of a bacterial or viral infection, including fever.
2. The subject is unwilling to allow a biopsy of a malignant lesion for histological
analysis.
3. The subject has a pace maker or other electronic device implanted
Ages Eligible for Study
18 Years - 75 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Irene Bailey-Healy
408-892-7261
Not Recruiting